From: Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III–IVA esophageal squamous cell carcinoma post-surgery
Complications and Clavien-Dindo classification
Observation group
Control group
P-value
Anastomotic fistula
3
6
1.0
Grade II
1
Grade III
2
Postoperative lung infection rate
7
0